Mrs Kathlene Lemay Bartko, LCSW | |
1101 Marshall Cir, Junction City, KS 66441-4500 | |
(785) 717-8641 | |
(270) 964-5084 |
Full Name | Mrs Kathlene Lemay Bartko |
---|---|
Gender | Female |
Speciality | Case Manager/care Coordinator |
Location | 1101 Marshall Cir, Junction City, Kansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1346442092 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | 6801076621 (Michigan) | Primary |
171M00000X | Case Manager/care Coordinator | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Kathlene Lemay Bartko, LCSW 1101 Marshall Cir, Junction City, KS 66441-4500 Ph: (785) 717-8641 | Mrs Kathlene Lemay Bartko, LCSW 1101 Marshall Cir, Junction City, KS 66441-4500 Ph: (785) 717-8641 |
News Archive
"By voting to ban any U.S. contribution to UNFPA" in the FY 2013 State and Foreign Operations appropriations bill, the House Appropriations Committee on Thursday "made a judgment call that saving the lives of women and girls around the world is simply not a U.S. priority," Valerie DeFillipo, president of Friends of UNFPA, writes in a Huffington Post "Global Motherhood" opinion piece.
Syrris, a world leader in chemistry product innovation, continues to support pioneering research into nanoparticle drug encapsulation, thanks to its award-winning Asia range of advanced flow chemistry modules.
S1 Pharmaceuticals, Inc. (S1) announced today that it has submitted its Investigational New Drug (IND) application to the U.S. Food and Drug Administration for Phase I-b clinical studies of SIP-104 (Lorexys). Lorexys is the Company's lead drug candidate for the treatment of Hypoactive Sexual Desire Disorder (HSDD) and Female Sexual Dysfunction (FSD).
In a process akin to belling an infinitesimal cat, scientists have managed to tag a protein that regulates the neurotransmitter serotonin with tiny fluorescent beads, allowing them to track the movements of single molecules for the first time.
› Verified 6 days ago